Fig. 5.
Effects of transforming growth factor-β (TGF-β) and interleukin-10 (IL-10) on in vitro cell migratory potential of HM-1-parental, control vector-transfected (HM-1-mock), and indoleamine 2,3-dioxygenase-overexpressing (HM-1-IDO) murine ovarian carcinoma OV2944-HM-1 cells. The cell migratory activity in the presence or absence of 1 ng/mL TGF-β or IL-10 was evaluated by wound healing assay after 24 h. Mean ± SD from three independent experiments are shown. *P < 0.05, TGF-β (+) versus control.